Skip to main content
. 2013 Nov 15;13:42. doi: 10.1186/1471-2253-13-42

Table 1.

Patient and tumor characteristics by blood transfusion status before and after matching

Factors All patients
P value Matched patients
P value
Non-transfused Transfused Non-transfused Transfused
Total n
576 (90.6%)
60 (9.4%)
 
90
45
 
Age (SD)
65.16 (10.54)
66.21 (9.46)
0.91
65.08 (10.8)
65.8 (10.12)
0.73
BMI (SD)
27.06 (5.31)
26.88 (7.33)
0.15
27.37 (5.76)
27.02 (7.59)
0.79
Gender
 
 
0.43
 
 
0.80
 Female
267 (89.6%)
31 (10.4%)
 
48 (67.6%)
23 (32.4%)
 
 Male
309 (91.4%)
29 (8.6%)
 
42 (65.6%)
22 (34.4%)
 
ASA
 
 
0.48
 
 
0.82
 2
62 (93.9%)
4 (6.1%)
 
9 (75%)
3 (25%)
 
 3
480 (90.4%)
51 (9.6%)
 
75 65.8%)
39 (34.2%)
 
 4
33 (86.8%)
5 (13.2%)
 
6 (66.7%)
3 (33.3%)
 
Stage
 
 
0.01
 
 
0.92
 1
328 (93.4%)
23 (6.6%)
 
32 (65.3%)
17 (34.7%)
 
 2
115 (87.8%)
16 (12.2%)
 
25 (65.8%)
13 (34.2%)
 
 3
131 (86.2%)
21 (13.8%)
 
33 (68.8%)
15 (31.3%)
 
Hb g/dL, (SD) 13.43 (1.42) 12.08 (1.58) < 0.0001 12.4 (1.3) 12.3 (1.4) 0.73

A p value < 0.05 was considered statistically significant. BMI Body mass index. ASA American Society of Anesthesiologist physical status. Hb Hemoglobin.